| Cat.No. | Name | Information |
|---|---|---|
| M1959 | Oseltamivir | Oseltamivir is a potent and selective inhibitor of influenza virus neuraminidase enzyme. |
| M5055 | Peramivir | Peramivir is a transition-state analogue and a potent, specific influenza viral neuraminidase inhibitor with an IC50 of median 0.09 nM. |
| M1707 | Entecavir Monohydrate | Entecavir Hydrate is a class of antiviral compounds. |
| M3357 | Telbivudine | Telbivudine (Epavudine) is an orally active, potent antiviral inhibitor of hepatitis B virus (HBV) replication. Telbivudine is an antiviral compound used in hepatitis B research. |
| M1695 | Cidofovir | Cidofovir (Vistide) is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis. |
| M4718 | Dendrobine | Dendrobine is an alkaloid isolated from Dendrobium nobile. Dendrobine has antiviral activity against influenza A virus, IC50 values for A/FM-1/1/47 (H1N1), A/Puerto Rico/8/34 H274Y (H1N1) and A/Aichi/2/68 (H3N2) were 3.39 μM, 2.16 μM and 5.32 μM, respectively. |
| M3222 | Peramivir Trihydrate | Peramivir Trihydrate is a trihydrate of the anti-infection agent peramivir (RWJ-270201,BCX-1812) which is a transition-state analogue and a potent, specific influenza viral neuraminidase inhibitor with an IC50 of median 0.09 nM. |
| M4789 | Isoscopoletin | Isoscopoletin (6-Hydroxy-7-methoxycoumarin) is an active ingredient in artemisia argyi leaves. Isoscopoletin showed significant inhibition of cell proliferation, with IC50 values of 4.0 μM and 1.6 μM against human CCRF-CEM leukemia cells and CEM/ADR5000 drug-resistant subline, respectively. Isoscopoletin (6-Hydroxy-7-methoxycoumarin) has the activity of inhibiting HBV replication. |
| M10082 | Amodiaquine | Amodiaquine is a 4-aminoquinoline compound related to chloroquine, used as an antimalarial and anti-inflammatory agent. |
| M7775 | 3-Deazaadenosine | 3-Deazaadenosine is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 µM, possesses antiviral activity inhibitor of leukocyte adhesion to TNF-treated endothelial cells. |
| M41258 | SARS-CoV-2 3CLpro-IN-13 | SARS-CoV-2 3CLpro-IN-13 is a potent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 21 nM. |
| M41257 | MTase-IN-1 | MTase-IN-1 is a potent and selective inhibitor of coronavirus nsp14 N7-methyltransferases, with an IC50 of 0.72 nM. |
| M41256 | E07 aptamer | SARS-CoV-2 nsp14-IN-4 is a selective SARS-CoV-2 nsp14 methyltransferase inhibitor with an IC50 value of 19 ± 2.5 nM. |
| M41255 | PLpro/RBD-IN-1 | PLpro/RBD-IN-1 is a dual SARS-CoV-2 PLpro and spike protein RBD inhibitor with IC50s of 7.197 μM and 8.673 μM, respectively. |
| M41254 | MPI60 | MPI60 is a potent SARS-CoV-2 MPro inhibitor with high antiviral potency, low cellular cytotoxicity, and high in vitro metabolic stability. |
| M41253 | Zevotrelvir | Zevotrelvir is a coronavirus inhibitor with IC50 ranges of <0.1 μM and <0.1mM for 229E hCoV and SARS-CoV-23C-like (3CL) proteases, respectively. |
| M41252 | Debrisoquin | Debrisoquin (Isocaramidine) is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. |
| M41251 | RdRP-IN-7 | RdRP-IN-7 is a RNA-dependent RNA polymerase (RdRp) inhibitor that shows the inhibition of SARS-CoV-2 infection with an IC50 of 8.2 μM, an IC90 of 14.1 μM and an CC90 of 79.1 μM. |
| M41209 | Nepasaikosaponin K | Nepasaikosaponin K is an anti-influenza agent. |
| M41208 | Neuraminidase-IN-15 | Neuraminidase-IN-15 is an inhibitor of neuraminidase. |
| M41207 | Neuraminidase-IN-14 | Neuraminidase-IN-14 is an inhibitor of neuraminidase. |
| M41206 | Neuraminidase-IN-12 | NDV-IN-1 is an antiviral agent with high neuraminidase inhibitory activity. |
| M41205 | FR198248 | FR198248 is an anti-influenza agent and peptide deformylase (PDF) inhibitor. |
| M41204 | Neuraminidase-IN-13 | Neuraminidase-IN-13 is a neuraminidase inhibitor with antiviral activity and low cytotoxicity. |
| M41203 | HA-IN-1 | HA-IN-1 is a Hemagglutinin (HA) ligand with high affinity, targeting to the trypsin cleavage site of HA. |
| M41202 | HAA-09 | HAA-09 is an orally active and potent anti-influenza agent, targeting the influenza PB2_cap binding domain. |
| M41201 | Tirfipiravir | Tirfipiravir is a nucleoside compound and antiviral agent, against the novel coronavirus or influenza virus. |
| M41200 | Viral polymerase-IN-1 hydrochloride | Viral polymerase-IN-1 hydrochloride, a Gemcitabine derivative, potently inhibits influenza A and B viruses infection with IC90 values of 11.4-15.9 μM. |
| M41199 | Influenza virus-IN-7 | Influenza virus-IN-7 is an orally active cap-dependent endonuclease inhibitor that can be used for the research of influenza viral infectious diseases. |
| M41198 | Neuraminidase-IN-16 | Neuraminidase-IN-16 is a potent neuraminidase inhibitor with IC50s of 0.031, 0.15, 0.25, 0.60, 0.63 and 10.08 μM against neuraminidase of H5N1, H5N8, H1N1, H3N2, H5N1-H274Y and H1N1-H274Y, respectively. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
